Kim Dong bought URGN
January 31, 2024 · Form 4 insider transaction
Kim Dong bought 12,000 shares of UroGen Pharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,000
Price
$0.00
Total value
N/A
InsiderKim Dong
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJanuary 31, 2024
Filing dateFebruary 2, 2024
Shares owned after12,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.; 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027.